David L. Shedlarz's most recent trade in Teladoc Health Inc was a trade of 28,986 Restricted Stock Units done . Disclosure was reported to the exchange on May 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Teladoc Health Inc | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 28,986 | 28,986 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | David L. Shedlarz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 17,467 | 32,280 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | David L. Shedlarz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2025 | 17,467 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 17,467 | 17,467 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | David L. Shedlarz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 9,834 | 14,813 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | David L. Shedlarz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 9,834 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 9,834 | 9,834 | - | - | Restricted Stock Units | |
| Pitney Bowes Inc | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2023 | 19,802 | 134,802 (0%) | 0% | 0 | Common Stock | |
| Pitney Bowes Inc | David L. Shedlarz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 19,802 | 0 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 6,726 | 6,726 | - | - | Restricted Stock Units | |
| Pitney Bowes Inc | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2022 | 19,802 | 37,700 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,638 | 1,638 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | David L. Shedlarz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2021 | 1,049 | 4,979 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | David L. Shedlarz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2021 | 1,049 | 0 | - | - | Restricted Stock Units | |
| Pitney Bowes Inc | David L. Shedlarz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2021 | 33,784 | 4,403 | - | - | Restricted Stock Units | |
| Pitney Bowes Inc | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 33,784 | 109,481 (0%) | 0% | 0 | Common Stock | |
| Pitney Bowes Inc | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2021 | 13,495 | 17,898 | - | - | Restricted Stock Units | |
| Hershey | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 129 | 16,342 (0%) | 0% | 0 | Common Stock | |
| Hershey | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 264 | 16,128 (0%) | 0% | 0 | Common Stock | |
| Hershey | David L. Shedlarz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 282 | 15,779 (0%) | 0% | 0 | Common Stock |